12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Monday's after-market session. Cingulate, G Medical Innovations, Taysha Gene Therapies, Exicure, Arcellx, and Codexis saw gains, while Alaunos Therapeutics, Design Therapeutics, OptimizeRx, TFF Pharmaceuticals, Delcath Systems, and Acer Therapeutics experienced losses. Q2 earnings reports were released for several of these companies.
August 14, 2023 | 9:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Arcellx's stock rose 9.79% after the release of their Q2 earnings report.
The stock rose significantly following the release of their Q2 earnings report, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Codexis' stock moved upwards by 8.62%.
The stock rose significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Cingulate's stock rose 15.4% in Monday's after-market session.
The stock rose significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
G Medical Innovations' shares moved upwards by 13.15%.
The stock rose significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Taysha Gene Therapies' stock increased by 12.66% after the release of their Q2 earnings report.
The stock rose significantly following the release of their Q2 earnings report, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Exicure's shares moved upwards by 11.11% following their Q2 earnings report.
The stock rose significantly following the release of their Q2 earnings report, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Acer Therapeutics' shares declined by 7.95%.
The stock fell significantly, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Delcath Systems' stock decreased by 10.9% following their Q2 earnings report.
The stock fell significantly following the release of their Q2 earnings report, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Design Therapeutics' shares fell 42.66% following their Q2 earnings report.
The stock fell significantly following the release of their Q2 earnings report, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
OptimizeRx's stock declined by 19.65% after the release of their Q2 earnings report.
The stock fell significantly following the release of their Q2 earnings report, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Alaunos Therapeutics' shares declined by 44.1%.
The stock fell significantly, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
TFF Pharmaceuticals' stock fell 17.87% following their Q2 earnings report.
The stock fell significantly following the release of their Q2 earnings report, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100